Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pro-inflammatory monocytes are a functionally defined subset of circulating monocytes capable of producing high levels of inflammatory cytokines such as TNFα, IL-1β, IL-6, and chemokines when stimulated, particularly via toll-like receptors[2][5][7]. In humans, the classical monocyte subset (CD14++CD16−) and the non-classical subset (CD14lowCD16++), depending on stimulus, can display pro-inflammatory functions, such as rapid secretion of cytokines, antigen presentation, phagocytosis, and orchestration of immune cell recruitment to sites of tissue damage or infection[1][5][8]. These cells play essential roles in host defense, but overactivation or dysregulation is implicated in the pathology of chronic inflammatory, autoimmune, cardiovascular, and infectious diseases[4][7]. "Pro-inflammatory monocyte" is an operational or descriptive label, not a unique molecular target or protein, and thus is not a canonical therapeutic target entity.
Modulation or inhibition of cytokine production (e.g., TNFα, IL-1β, IL-6 inhibitors); Suppression of monocyte activation or differentiation; Inhibition of chemokine/adhesion molecule pathways
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pro-inflammatory monocyte.